Amylyx Pharmaceuticals Inc (AMLX)
2.03
+0.10
(+5.18%)
USD |
NASDAQ |
May 02, 14:13
Amylyx Pharmaceuticals Gross Profit (Quarterly): 99.09M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 99.09M |
| September 30, 2023 | 97.48M |
| June 30, 2023 | 92.64M |
| March 31, 2023 | 66.14M |
| December 31, 2022 | 19.06M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.173M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2021
99.09M
Maximum
Dec 2023
37.46M
Average
9.618M
Median
Gross Profit (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| iRhythm Technologies Inc | 87.43M |
| Bristol-Myers Squibb Co | 8.933B |
| Moderna Inc | 1.884B |
| ACADIA Pharmaceuticals Inc | 213.15M |